![]() |
市场调查报告书
商品编码
1302938
全球旋转阀市场 - 2023-2028 年预测Global Rotary Valve Market - Forecasts from 2023 to 2028 |
旋转阀是一种通过旋转横向止动件中的通道来控制液体或气体通过连接管道的流量的阀门。 旋转阀最基本的类型是普通旋塞阀。 包括化工行业在内的各行业对节能产品的需求不断增加,以及节水有益健康的意识不断增强,都推动了旋转阀市场的增长。 此外,由于疫情加剧,多个政府机构增加对製药行业的投资也将推动预测期内旋转阀市场的增长。
旋转阀是化学工业中使用的主要部件之一,用作过程流体的控制阀、密封件和安全措施。 它还允许在各种压力下进行无洩漏流量调节并提供灵活性。 化学工业产量的增加预计将推动旋转阀市场的增长。 根据美国经济分析局的数据,2021年化学工业为美国经济贡献了4400亿美元。 根据网络安全和基础设施安全局(CISA)的数据,美国化学工业是全球第二大化学品生产国,全球13%的化学品来自美国。 化学工业生产市场的增长预计将推动旋转阀市场的增长。
旋转阀专为製药和营养品行业的卫生研磨和粉碎应用而製造。 製药行业中旋转阀的用途是阻止和调节自由流动的材料。 旋转阀可以均匀、连续地输送粉末、颗粒或散装材料。 製药行业产量的增加预计将推动旋转阀市场的增长。 国务院预计,2021年,我国医药业务收入预计将超过3.3万亿元,同比增长近20%。 据IBEF统计,2000年4月至2022年6月,印度製药和医疗保健行业的直接投资总额约为199亿美元。 根据同一份文件,印度的製药业随着时间的推移已经发展成为一个强大的行业,目前在药品产量方面排名世界第三。 这表明製药行业产量的增加将推动预测期内旋转阀市场的增长。
由于製药、食品和饮料行业等各个行业对旋转阀应用的需求不断增加,预计亚太地区将占据主要市场份额。 亚洲製药行业投资的增加预计将推动市场增长。 例如,根据印度品牌资产基金会的数据,2021 年 9 月,印度政府承诺向製药和医疗保健行业提供约 40 亿美元。 2019年7月,Cipla宣布与江苏创诺药业成立中国合资公司。 印度公司将拥有总投资3000万美元的80%。 新业务将在中国建立一家製造工厂,生产呼吸产品。 政府和市场参与者对製药行业投资的增加也推动了预测期内旋转阀市场的增长。
A rotary valve is a type of valve in which the flow of liquid or gas through the connected pipes is controlled by rotating a passage in a transverse stopper. The most basic type of rotary valve is the common stopcock. Increased demand for energy-efficient products across various industries, including the chemical sector, and growing awareness of the health benefits of conserving water are fueling the growth of the rotary valve market. The growing investment in the pharmaceutical industry by several government bodies due to the increasing pandemic will also boost the growth of the global rotary valve market during the forecasted period.
The rotary valve is one of the key components used in the chemical industry, acting as a control valve, a seal, and a means of safety for process fluids. It also offers flexibility by allowing leak-free flow rate regulation at varied pressures. The growing production in the chemical industry will boost the rotary valve market growth. According to the US Bureau of Economic Analysis, the chemicals industry contributed $ 440 billion to the US economy in 2021. According to the Cybersecurity and Infrastructure Security Agency (CISA), The U.S. chemical industry is the world's second-largest chemical producer, with 13% of the world's chemicals coming from the United States. This growing chemical industry production market is anticipated to boost the global rotary valve market growth.
The rotary valve is specifically made for hygienic milling and micronization applications in the pharmaceutical and nutraceutical industries. The purpose of the rotary valve in the pharmaceutical industry is to stop and regulate free-flowing materials. They allow uniform dosing and continuous feeding of powders, granulates, or bulk materials. The growing production in the pharmaceutical industry will boost the rotary valve market growth. According to the State Council People's Republic of China, In 2021, China's pharmaceutical business will earn over 3.3 trillion yuan in revenue, indicating a nearly 20% increase year on year. According to IBEF, between April 2000 and June 2022, FDI investment into the Indian pharmaceutical and medicine sector totaled around US$19.90 billion. Also, as per the same source, the Indian pharmaceutical sector has developed over time into a robust and is currently rated third in the world in terms of pharmaceutical production volume. This shows that the growing production in the pharmaceutical sector will boost the global rotary valve market growth during the forecasted period.
The Asia Pacific region is anticipated to constitute a significant market share due to the growing demand for rotary valve applications in various sectors, including the pharmaceutical and food and beverage industries. The growing pharmaceutical industry investment in Asia is expected to boost market growth. For instance, In September 2021, according to the Indian Brand Equity Foundation, the Indian government contributed around $4 billion to the pharmaceutical and medical industry. In July 2019, Cipla announced the formation of a Chinese joint venture with Jiangsu Acebright Pharmaceutical. The Indian firm will own 80% of the total $30 million investment. The new business would establish a manufacturing plant in China to produce respiratory products. The growing pharmaceutical industry investments by the government and market players are also boosting the rotary valve market growth during the forecasted period.
Market Segmentation